Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001848341 | SCV002106222 | uncertain significance | Hereditary spastic paraplegia | 2020-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002545268 | SCV003536499 | uncertain significance | Inborn genetic diseases | 2022-10-27 | criteria provided, single submitter | clinical testing | The c.973C>A (p.L325M) alteration is located in exon 9 (coding exon 9) of the AP5Z1 gene. This alteration results from a C to A substitution at nucleotide position 973, causing the leucine (L) at amino acid position 325 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |